Autism Spectrum Disorder Trial, Recruiting NCT05987774 Sponsor: Stanford University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT05987774
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a formal diagnosis of autism spectrum disorder (ASD)
  • People aged between 11 and 35 years old
  • People who are able to hold a social conversation using full sentences for around 20 minutes
  • People who show difficulty in a specific area of conversation (for example, showing empathy), as identified through a conversation assessment
  • People with an additional diagnosis of ADHD, depression, or social anxiety are still welcome, as these are common alongside ASD

Who may not be able to join:

  • People whose ASD diagnosis is not formally documented, or who have only self-diagnosed
  • People who already perform at or above 60% accuracy in the targeted conversation area during the assessment
  • People who do not have access to a phone or computer for the intervention sessions
  • People who are unable to carry on a conversation during the conversation assessment
  • People whose intellectual difficulties significantly interfere with conversation ability — for example, responding only in single words, not responding at all, or not appearing to understand questions during the assessment
  • People who do not speak English
  • People with serious medical or psychiatric conditions that may interfere with conversation or completing the program
  • People who are not interested in participating

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8056899493

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 October 2023
Est. completion
30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Social Conversation Sample

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov